Mechanisms regulating airway nucleotides

Sub-Cellular Biochemistry

Volumn 55, Issue , 2011, Pages 17-49

  Picher, Maryse ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Alkaline phosphatase; CD39; CD73; Ectoenzyme; Ectonucleotidase

Indexed keywords

ADENINE NUCLEOTIDE; HYDROLASE; NUCLEOTIDE TRANSPORTER; PURINERGIC RECEPTOR;

ANIMAL; EPITHELIUM CELL; HUMAN; HYDROLYSIS; METABOLISM; RESPIRATORY TRACT MUCOSA; REVIEW; SIGNAL TRANSDUCTION; TRANSPORT AT THE CELLULAR LEVEL;

ADENINE NUCLEOTIDES; ANIMALS; BIOLOGICAL TRANSPORT; EPITHELIAL CELLS; HUMANS; HYDROLASES; HYDROLYSIS; NUCLEOTIDE TRANSPORT PROTEINS; RECEPTORS, PURINERGIC; RESPIRATORY MUCOSA; SIGNAL TRANSDUCTION;

EID: 84875438466     PISSN: 03060225     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-94-007-1217-1_2     Document Type: Article

References (207)

1. Enjyoji K, Sevigny J, Lin Y, Frenette PS, Christie PD, Esch JS II, Imai M, Edelberg JM, Rayburn H, Lech M, Beeler DL, Csizmadia E, Wagner DD, Robson SC, Rosenberg RD, Imai M, Edelberg JM, Rayburn H, Lech M, Beeler DL, Csizmadia E, Wagner DD, Robson SC, Rosenberg RD (1999) Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med 5:1010–1017
2. Goepfert C, Imai M, Brouard S, Csizmadia E, Kaczmarek E, Robson SC (2000) CD39 modulates endothelial cell activation and apoptosis. Mol Med 6:591–603
3. Jhandier MN, Kruglov EA, Lavoie EG, Sevigny J, Dranoff JA (2005) Portal fibroblasts regulate the proliferation of bile duct epithelia via expression of NTPDase2. J Biol Chem 280:22986–22992
4. Zimmermann H (2000) Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedeberg’s Arch Pharmacol 362:299–309
5. Moss DW (1992) Perspective in alkaline phosphatase research. Clin Chem 38:2486–2492
6. Henderson RF (2005) Use of bronchoalveolar lavage to detect respiratory tract toxicity of inhaled material. Exp Toxicol Pathol 57:155–159
7. Van Belle H (1976) Alkaline phosphatase. I. Kinetics and inhibition by levamisole of purified isoenzymes from humans. Clin Chem 22:972–976
8. Milla´n J (2006) Alkaline phosphatases. Purinergic Signal 2:335–341
9. Van Hoof VO, De Broe ME (1994) Interpretation and clinical significance of alkaline phosphatase isoenzyme patterns. Crit Rev Clin Lab Sci 31:197–293
10. Ali M, Gawin AZ, Baraniuk JN (1996) Effects of bombesin family peptides and antagonists on guinea pig nasal mucosal secretion. J Pharmacol Exp Ther 276:1266–1271
11. Brindley DN, English D, Pilquil C, Buri K, Ling ZC (2002) Lipid phosphate phosphatases regulate signal transduction through glycerolipids and sphingolipids. Biochim Biophys Acta 1582:33–44
12. Borgers M, Thone´ F (1975) The inhibition of alkaline phosphatase by L-p-bromotetramisole. Histochemistry 44:277–280
13. Goldstein DJ, Rogers C, Harris H (1982) A search for trace expression of placental-like alkaline phosphatase in non-malignant human tissues: demonstration of its occurrence in lung, cervix, testis and thymus. Clin Chim Acta 125:63–75
14. Nouwen EJ, Buyssens N, De Broe ME (1990) Heat-stable alkaline phosphatase as a marker for human and monkey type-I pneumocytes. Cell Tissue Res 260:321–335
15. Miyanaga M, Sugimoto H, Komoda T, Nosjean O, Honma K, Nemoto K, Sato T (1996) A variant alkaline phosphatase detected in a patient with lung cancer. Enzyme Protein 49:313–320
16. Sergienko E, Su Y, Chan X, Brown B, Hurder A, Narisawa S, Millan JL (2009) Identification and characterization of novel tissue-nonspecific alkaline phosphatase inhibitors with diverse modes of action. J Biomol Screen 14:824–837
17. Sidique S, Ardecky R, Su Y, Narisawa S, Brown B, Millan JL, Sergienko E, Cosford ND (2009) Design and synthesis of pyrazole derivatives as potent and selective inhibitors of tissue-nonspecific alkaline phosphatase (TNAP). Bioorg Med Chem Lett 19:222–225
18. Lanier M, Sergienko E, Simao AM, Su Y, Chung T, Millan JL, Cashman JR (2009) Design and synthesis of selective inhibitors of placental alkaline phosphatase. Bioorg Med Chem 18:573–579
19. Ikehara Y, Mansho K, Takahashi K, Kato K (1978) Purification and characterization of alkaline phosphatase from plasma membranes of rat ascites hepatoma. J Biochem 83:1471–1483
20. Say JC, Ciuffi K, Furriel RP, Ciancaglini P, Leone FA (1991) Alkaline phosphatase from rat osseous plates: purification and biochemical characterization of a soluble form. Biochim Biophys Acta 1074:256–262
21. Fortuna R, Anderson HC, Carty RP, Sajdeja SW (1980) Enzymatic characterization of the matrix vesicle alkaline phosphatase isolated from bovine epiphyseal cartilage. Calcif Tissue Int 30:217–225
22. Demenis MA, Furriel RPM, Leone FA (2003) Characterization of an ectonucleoside triphosphate diphosphohydrolase 1 activity in alkaline phosphatase-depleted rat osseous plate membranes: possible functional involvement in the calcification process. Biochim Biophys Acta 1646:216–225
23. Pizauro JM, Ciancaglini P, Leone FA (1993) Allosteric modulation by ATP, calcium and magnesium ions of rat osseous plate alkaline phosphatase. Biochim Biophys Acta 1202:22–28
24. Corbic M, de Coue¨t G, Bertrand O, Cochet S, Erlinger S (1985) Bicarbonate-stimulated ATPase activity of bovine liver alkaline phosphatase. J Hepatol 1:167–178
25. Nouwen EJ, Pollet DE, Eerdekens MW, Hendrix PG, Briers TW, De Broe ME (1986) Immunohistochemical localization of placental alkaline phosphatase, carcinoembryonic antigen, and cancer antigen 125 in normal and neoplastic human lung. Cancer Res 46:866–876
26. Picher M, Burch LH, Hirsh AJ, Spychala J, Boucher RC (2003) Ecto 50-nucleotidase and nonspecific alkaline phosphatase. Two AMP-hydrolyzing ectoenzymes with distinct roles in human airways. J Biol Chem 278:13468–13479
27. Picher M, Burch LH, Boucher RC (2004) Metabolism of P2 receptor agonists in human airways: implications for mucociliary clearance and cystic fibrosis. J Biol Chem 279:20234–20241
28. Capelli A, Cerutti CG, Lusuardi M, Donner CF (1997) Identification of human pulmonary alkaline phosphatase isoenzymes. Am J Respir Crit Care Med 155:1448–1452
29. Henderson RF, Scott GG, Waide JJ (1995) Source of alkaline phosphatase activity in epithelial lining fluid of normal and injured F344 rat lungs. Toxicol Appl Pharmacol 134:170–174
30. DiAugustine RP (1974) Lung concentric laminar organelle. Hydrolase activity and compositional analysis. J Biol Chem 249:584–593
31. Edelson JD, Shannon JM, Mason RJ (1988) Alkaline phosphatase: a marker of alveolar type II cell differentiation. Am Rev Respir Dis 138:1268–1275
32. Xie E, Yang ZQ, Li A (1996) Determination of placental alkaline phosphatase (PLAP) for detecting the damages of alveolar type I cells caused by smoke inhalation. Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi 12:427–430
33. Swain RJ, Kemp SJ, Goldstraw P, Tetley TD, Stevens MM (2008) Spectral monitoring of surfactant clearance during alveolar epithelial type II cell differentiation. Biophys J 95:5978–5987
34. Fedde KN, Lane CC, Whyte MP (1988) Alkaline phosphatase is an ectoenzyme that acts on micromolar concentrations of natural substrates at physiologic pH in human osteosarcoma (SAOS-2) cells. Arch Biochem Biophys 264:400–409
35. Marquez C, Toribio ML, Marcos MA, de la Hera A, Barcena A, Pezzi L, Martinez C (1989) Expression of alkaline phosphatase in murine B lymphocytes. Correlation with B cell differentiation into Ig secretion. J Immunol 142:3187–3192
36. Baggiolini M (1972) The enzymes of the granules of polymorphonuclear leukocytes and their functions. Enzyme 13:132–160
37. Garattini E, Gianni M (1996) Leukocyte alkaline phosphatase a specific marker for the post-mitotic neutrophilic granulocyte: regulation in acute promyelocytic leukemia. Leuk Lymphoma 23:493–503
38. Jiang X, Kobayashi T, Nahirney PC, Garcıa del Saz E, Seguchi H (1998) An ultracytochemical study on the dynamics of alkaline phosphatase-positive granules in rat neutrophils. Histol Histopathol 13:57–65
39. Jiang X, Kobayashi T, Nahirney PC, del Garcia SE, Seguchi H (1996) Ultracytochemical localization of alkaline phosphatase (ALPase) activity in neutrophils of the rat lung following injection of lipopolysaccharide. Kaibogaku Zasshi 71:183–194
40. Day DF, Ingram JM (1973) Purification and characterization of Pseudomonas aeruginosa alkaline phosphatase. Can J Microbiol 19:1225–1233
41. Kadurugamuwa JL, Beveridge TJ (1997) Natural release of virulence factors in membrane vesicles by Pseudomonas aeruginosa and the effect of aminoglycoside antibiotics on their release. J Antimicrob Chemother 40:615–621
42. Bomberger JM, Maceachran DP, Coutermarsh BA, Ye S, O’Toole GA, Stanton BA (2009) Long-distance delivery of bacterial virulence factors by Pseudomonas aeruginosa outer membrane vesicles. PLoS Pathog 5:e1000382
43. Rietschel ET, Kirikae T, Schade FU, Mamat U, Schmidt G, Loppnow H, Ulmer AJ, Zahringer U, Seydel U, Di Padova F (1994) Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J 8:217–225
44. Holst O, Thomas-Oates JE, Brade H (1994) Preparation and structural analysis of oligosaccharide monophosphates obtained from the lipopolysaccharide of recombinant strains of Salmonella minnesota and Escherichia coli expressing the genus-specific epitope of Chlamydia lipopolysaccharide. Eur J Biochem 222:183–194
45. Poelstra K, Bakker WW, Klok PA, Kamps JA, Hardonk M, Meijer DK (1997) Dephosphorylation of endotoxin by alkaline phosphatase in vivo. Am J Pathol 151:1163–1169
46. Bentala H, Verweij WR, Huizinga-van der Vlag A, Huizinga-vander Vlag A, van Loenen-Weemaes AM, Meijer DK, Meijer DK, Poelstra K (2002) Removal of phosphate from lipid A as a strategy to detoxify lipopolysaccharide. Shock 18:561–566
47. Beumer C, Wulferink M, Raaben W, Raaben W, Fiechter DL, Brands R, Seinen W (2003) Calf intestinal alkaline phosphatase, a novel therapeutic drug for lipopolysaccharide (LPS)-mediated diseases, attenuates LPS toxicity in mice and piglets. J Pharmacol Exp Ther 307:737–744
48. Koyama I, Matsunaga T, Harada T, Hokari S, Komoda T (2002) Alkaline phosphatases reduce toxicity of lipopolysaccharide in vivo and in vitro through dephosphorylation. Clin Biochem 36:455–461
49. Poelstra K, Bakker WW, Klok PA, Hardonk MJ, Meijer DK (1997) A physiologic function for alkaline phosphatase: endotoxin detoxification. Lab Invest 76:319–327
50. Geddes K, Philpott DJ (2008) A new role for intestinal alkaline phosphatase in gut barrier maintenance. Gastroenterology 135:8–12
51. Tuin A, Poelstra K, de Jager-Krikken A, Bok L, Raaben W, Velders MP, Dijkstra G (2009) Role of alkaline phosphatase in colitis in man and rats. Gut 58:379–387
52. Goldberg RF, Austen WGJ, Zhang X, Munene G, Mostafa G, Biswas S, McCormack M, Eberlin KR, Nguyen JT, Tatlidede HS, Warren HS, Narisawa S, Millan JL, Hodin RA (2008) Intestinal alkaline phosphatase is a gut mucosal defense factor maintained by enteral nutrition. Proc Natl Acad Sci USA 105:3551–3556
53. Picher M, Boucher RC, Picher M, Boucher RC, Picher M, Boucher RC (2003) Detoxification of Pseudomonas aeruginosa lipopolysaccharide in human airways: an inflammatory response mediated by non-specific alkaline phosphatase. Pediatr Pulmonol Suppl 25:271
54. Beaudoin AR, Sevigny J, Picher M (1996) ATP-diphosphohydrolases, apyrases and nucleotide phosphohydrolases: biochemical properties and functions. JAI Press, Greenwich
55. Robson SC, Sevigny J, Zimmermann H (2006) The E-NTPDase family of ectonucleotidases: structure function relationships and pathological significance. Purinergic Signal 2:409–430
56. Christoforidis S, Papamarcaki T, Galaris D, Kellner R, Tsolas O (1995) Purification and properties of human placental ATP diphosphohydrolase. Eur J Biochem 234:66–74
57. Sevigny J, Sundberg C, Braun N, Guckelberger O, Csizmadia E, Qawi I, Imai M, Zimmermann H, Robson SC (2002) Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulation. Blood 99:2801–2809
58. Kukulski F, Levesque SA, Lavoie EG, Lecka J, Bigonnesse F, Knowles AF, Robson S, Kirley TL, Sevigny J (2005) Comparative hydrolysis of P2 receptor agonists by NTPDase 1, 2, 3 and Purinergic Signal 1:193–204
59. Mateo J, Harden TK, Boyer JL (1999) Functional expression of a cDNA encoding a human ecto-ATPase. Br J Pharmacol 128:396–402
60. Knowles AF, Chiang WC (2003) Enzymatic and transcriptional regulation of human ecto-ATPase/E-NTPDase Arch Biochem Biophys 418:217–227
61. Sevigny J, Robson SC, Waelkens E, Csizmadia E, Smith RN, Lemmens R (2000) Identification and characterization of a novel hepatic canalicular ATP diphosphohydrolase. J Biol Chem 275:5640–5647
62. Zimmermann H (2001) Ectonucleotidases: some recent developments and a note on nomenclature. Drug Dev Res 52:44–56
63. Kirley TL, Crawford PA, Smith TM (2006) The structure of the nucleoside triphosphate diphosphohydrolases (NTPDases) as revealed by mutagenic and computational modeling analyses. Purinergic Signal 2:379–389
64. Gendron FP, Benrezzak O, Krugh BW, Kong Q, Weisman GA, Beaudoin AR (2002) Purine signaling and potential new therapeutic approach: possible outcomes of NTPDase inhibition. Curr Drug Targets 3:229–245
65. Munkonda MN, Kauffenstein G, Kukulski F, Levesque SA, Legendre C, Pelletier J, Lavoie EG, Lecka J, Sevigny J (2007) Inhibition of human and mouse plasma membrane bound NTPDases by P2 receptor antagonists. Biochem Pharmacol 74:1524–1534
66. Leal DBR, Streher CA, Neu TN, Bittencourt FP, Leal CAM, da Silva JEP, Morsch VM, Schetinger MRC (2005) Characterization of NTPDase (NTPDase1; ecto-apyrase; ectodiphosphohydrolase; CD39; EC 3.6.1.5) activity in human lymphocytes. Biochim Biophys Acta 1721:9–15
67. Smith TM, Kirley TL (1998) Cloning, sequencing and expression of a human brain ecto-apyrase related to both the ecto-ATPase and CD39 ecto-apyrase1. Biochim Biophys Acta 1386:65–78
68. Shi XJ, Knowles AF (1994) Prevalence of the mercurial-sensitive ectoATPase in human small cell lung carcinoma: characterization and partial purification. Arch Biochem Biophys 315:177–184
69. Fausther M, Lecka J, Kukulski F, Levesque SA, Pelletier J, Zimmermann H, Dranoff JA, Sevigny J (2007) Cloning, purification, and identification of the liver canalicular ecto- ATPase as NTPDase8. Am J Physiol 292:G785–G795
70. Iqbal J, Vollmayer P, Braun N, Zimmermann H, Muller CE (2005) A capillary electrophoresis method for the characterization of ecto-nucleoside triphosphate diphosphohydrolases (NTPDases) and the analysis of inhibitors by in-capillary enzymatic microreaction. Purinergic Signal 1:349–358
71. Muller CE, Iqbal J, Baqi Y, Zimmermann H, Rollich A, Stephan H (2006) Polyoxometalatesa new class of potent ecto-nucleoside triphosphate diphosphohydrolase (NTPDase) inhibitors. Bioorg Med Chem Lett 16:5943–5947
72. Munkonda MN, Pelletier J, Ivanenkov VV, Fausther M, Tremblay A, Kunzli B, Kirley TL, Sevigny J (2009) Characterization of a monoclonal antibody as the first specific inhibitor of human NTP diphosphohydrolase-3. FEBS J 276:479–496
73. Baqi Y, Weyler S, Iqbal J, Zimmermann H, M€uller CE (2009) Structure-activity relationships of anthraquinone derivatives derived from bromaminic acid as inhibitors of ectonucleoside triphosphate diphosphohydrolases (E-NTPDases). Purinergic Signal 5:91–106
74. Knowles AF, Isler RE, Reece JF (1983) The common occurrence of ATP diphosphohydrolase in mammalian plasma membranes. Biochim Biophys Acta 731:88–96
75. Kaczmarek E, Koziak K, Sevigny J, Siegel JB, Anrather J, Beaudoin AR, Bach FH, Robson SC (1996) Identification and characterization of CD39/vascular ATP diphosphohydrolase. J Biol Chem 271:33116–33122
76. Marcus AJ, Broekman MJ, Drosopoulos JH, Islam N, Alyonycheva TN, Safier LB, Hajjar KA, Posnett DN, Schoenborn MA, Schooley KA, Gayle RB, Maliszewski CR (1997) The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. J Clin Invest 99:1351–1361
77. Ghijsen WE, de Jong MD, van Os CH (1980) Dissociation between Ca2+-ATPase and alkaline phosphatase activities in plasma membranes of rat duodenum. Biochim Biophys Acta 599:538–591
78. Rucker B, Almeida ME, Libermann TA, Zerbini LF, Wink MR, Sarkis JJ (2007) Biochemical characterization of ecto-nucleotide pyrophosphatase/phosphodiesterase (E-NPP, E.C. 3.1.4.1) from rat heart left ventricle. Mol Cell Biochem 306:247–254
79. Sato E, Suzuki T, Hoshi N, Sugino T, Hasegawa H (2008) Sodium azide induces necrotic cell death in rat squamous cell carcinoma SCC131. Med Mol Morphol 41:211–220
80. Crack BE, Pollard CE, Beukers MW, Roberts SM, Hunt SF, Ingall AH, McKechnie KC, IJzerman AP, Leff P (2005) Pharmacological and biochemical analysis of FPL 67156, a novel, selective inhibitor of ecto-ATPase. Br J Pharmacol 114:475–481
81. Westfall TD, Kennedy C, Sneddon P (1996) Enhancement of sympathetic purinergic neurotransmission in the guinea-pig isolated vas deferens by the novel ecto-ATPase inhibitor ARL 67156. Br J Pharmacol 117:867–872
82. Le´vesque SA, Lavoie EG, Lecka J, Bigonnesse F, Sevigny J (2007) Specificity of the ecto- ATPase inhibitor ARL 67156 on human and mouse ectonucleotidases. Br J Pharmacol 152:141–150
83. Kohler D, Eckle T, Faigle M, Grenz A, Mittelbronn M, Laucher S, Hart ML, Robson SC, Muller CE, Eltzschig HK (2007) CD39/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia-reperfusion injury. Circulation 116:1784–1794
84. Reutershan J, Vollmer I, Stark S, Wagner R, Ngamsri K-C, Eltzschig HK (2009) Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs. FASEB J 23:473–482
85. Martın-Satue M, Lavoie EG, Pelletier J, Fausther M, Csizmadia E, Guckelberger O, Robson SC, Sevigny J (2009) Localization of plasma membrane bound NTPDases in the murine reproductive tract. Histochem Cell Biol 131:615–628
86. Wall MJ, Wigmore G, Lopatar J, Frenguelli BG, Dale N (2008) The novel NTPDase inhibitor sodium polyoxotungstate (POM-1) inhibits ATP breakdown but also blocks central synaptic transmission, an action independent of NTPDase inhibition. Neuropathology 55:1251–1258
87. Chadwick B, Frischauf AM (1997) Cloning and mapping of a human and mouse gene with homology to ecto-ATPase genes. Mamm Genome 8:668–672
88. Chadwick BP, Frischauf AM (1998) The CD39-like gene family: identification of three new human members (CD39L2, CD39L3, and CD39L4), their murine homologues, and a member of the gene family from Drosophila melanogaster. Genomics 50:357–367
89. Eckle T, Fullbier L, Wehrmann M, Khoury J, Mittelbronn M, Ibla J, Rosenberger P, Eltzschig HK (2007) Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury. J Immunol 178:8127–8137
90. Sevigny J, Picher M, Grondin G, Beaudoin AR (1997) Purification and immunohistochemical localization of the ATP diphosphohydrolase in bovine lungs. Am J Physiol 272: L939–L950
91. Fausther M, Pelletier J, Ribeiro CM, Sevigny J, Picher M (2010) Cystic fibrosis remodels the regulation of purinergic signaling by NTPDase1 (CD39) and NTPDase3. Am J Physiol 298: L804–L818
92. Kreda SM, Gynn MC, Fenstermacher DA, Boucher RC, Gabriel SE (2001) Expression and localization of epithelial aquaporins in the adult human lung. Am J Respir Cell Mol Biol 24:224–234
93. Zinchuk VS, Okada T, Seguchi H (2001) Lipopolysaccharide alters ecto-ATP-diphosphohydrolase and causes relocation of its reaction product in experimental intrahepatic cholestasis. Cell Tissue Res 304:103–109
94. Kreda SM, Okada SF, van Heusden CA, O’Neal W, Gabriel S, Abdullah L, Davis CW, Boucher RC, Lazarowski ER (2007) Coordinated release of nucleotides and mucin from human airway epithelial Calu-3 cells. J Physiol 584:245–259
95. Davis CW, Lazarowski E (2008) Coupling of airway ciliary activity and mucin secretion to mechanical stresses by purinergic signaling. Respir Physiol Neurobiol 163:208–213
96. Yegutkin G, Bodin P, Burnstock G (2000) Effect of shear stress on the release of soluble ecto-enzymes ATPase and 50-nucleotidase along with endogenous ATP from vascular endothelial cells. Br J Pharmacol 129:921–926
97. Sørensen CE, Amstrup J, Rasmussen HN, Ankorina-Stark I, Novak I (2003) Rat pancreas secretes particulate ecto-nucleotidase CD39. J Physiol 551:881–892
98. Goding JW, Grobben B, Slegers H (2003) Physiological and pathophysiological functions of the ecto-nucleotide pyrophosphatase/phosphodiesterase family. Biochim Biophys Acta 1638:1–19
99. Stefan C, Jansen S, Bollen M (2005) NPP-type ectophosphodiesterases: unity in diversity. Trends Biochem Sci 30:542–550
100. Jansen S, Stefan C, Creemers JWM, Waelkens E, Van Eynde A, Stalmans W, Bollen M (2005) Proteolytic maturation and activation of autotaxin (NPP2), a secreted metastasisenhancing lysophospholipase D. J Cell Sci 118:3081–3089
101. Boutin J, Ferry G (2009) Autotaxin. Cell Mol Life Sci 66:3009–3021
102. Murata J, Lee HY, Clair T, Krutzsch HC, Arestad AA, Sobel ME, Liotta LA, Stracke ML (1994) cDNA cloning of the human tumor motility-stimulating protein, autotaxin, reveals a homology with phosphodiesterases. J Biol Chem 269:30479–30484
103. Lee HY, Murata J, Clair T, Polymeropoulos MH, Torres R, Manrow RE, Liotta LA, Stracke ML (1996) Cloning, chromosomal localization, and tissue expression of autotaxin from human teratocarcinoma cells. Biochem Biophys Res Commun 218:714–719
104. Kawagoe H, Soma O, Goji J, Nishimura N, Narita M, Inazawa J, Nakamura H, Sano K (1995) Molecular cloning and chromosomal assignment of the human brain-type phosphodiesterase I/nucleotide pyrophosphatase gene (PDNP2). Genomics 30:380–384
105. Giganti A, Rodriguez M, Fould B, Moulharat N, Coge´ F, Chomarat P, Galizzi JP, Valet P, Saulnier-Blache JS, Boutin JA, Ferry G (2008) Murine and human autotaxin alpha, beta, and gamma isoforms: gene organization, tissue distribution, and biochemical characterization. J Biol Chem 283:7776–7789
106. Rebbe NF, Tong BD, Hickman S (1993) Expression of nucleotide pyrophosphatase and alkaline phosphodiesterase I activities of PC-1, the murine plasma cell antigen. Mol Immunol 30:87–93
107. Clair T, Lee HY, Liotta LA, Stracke ML (1997) Autotaxin is an exoenzyme possessing 50-nucleotide phosphodiesterase/ATP pyrophosphatase and ATPase activities. J Biol Chem 272:996–1001
108. Grobben B, Anciaux K, Roymans D, Stefan C, Bollen M, Esmans EL, Slegers H (1999) An ecto-nucleotide pyrophosphatase is one of the main enzymes involved in the extracellular metabolism of ATP in rat C6 glioma. J Neurochem 72:826–834
109. Sakura H, Nagashima S, Nakashima A, Maeda M (1998) Characterization of fetal serum 50-nucleotide phosphodiesterase: a novel function as a platelet aggregation inhibitor in fetal circulation. Thromb Res 91:83–89
110. Grobben B, Claes P, Roymans D, Esmans EL, Van Onckelen H, Slegers H (2000) Ectonucleotide pyrophosphatase modulates the purinoceptor-mediated signal transduction and is inhibited by purinoceptor antagonists. Br J Pharmacol 130:139–145
111. Joseph SM, Pifer MA, Przybylski RJ, Dubyak GR (2004) Methylene ATP analogs as modulators of extracellular ATP metabolism and accumulation. Br J Pharmacol 142:1002–1014
112. Iqbal J, Levesque SA, Sevigny J, Muller CE (2008) A highly sensitive CE-UV method with dynamic coating of silica-fused capillaries for monitoring of nucleotide pyrophosphatase / phosphodiesterase reactions. Electrophoresis 29:3685–3693
113. Khan KM, Fatima N, Rasheed M, Jalil S, Ambreen N, Perveen S, Choudhary MI (2009) 1, 3, 4-Oxadiazole-2(3 H)-thione and its analogues: a new class of non-competitive nucleotide pyrophosphatases /phosphodiesterases 1 inhibitors. Bioorg Med Chem 17:7816–7822
114. Goldstein LB (2007) Statins for stroke prevention. Curr Atheroscler Rep 9:305–311
115. Majlesi Y, Samorapoompichit P, Hauswirth AW, Schernthaner G-H, Ghannadan M, Baghestanian M, Rezaie-Majd A, Valenta R, Sperr WR, Buhring H-J, Valent P (2003) Cerivastatin and atorvastatin inhibit IL-3-dependent differentiation and IgE-mediated histamine release in human basophils and downmodulate expression of the basophil-activation antigen CD203c/E-NPP3. J Leukoc Biol 73:107–117
116. B€uhring HJ, Streble A, Valent P (2004) The basophil-specific ectoenzyme E-NPP3 (CD203c) as a marker for cell activation and allergy diagnosis. Int Arch Allergy Immunol 133:317–329
117. Henz SL, Cognato Gde P, Vuaden FC, Bogo MR, Bonan CD, Sarkis JJ (2009) Influence of antidepressant drugs on ecto-nucleotide pyrophosphatase/phosphodiesterases (E-NPPs) from salivary glands of rats. Arch Oral Biol 54:730–736
118. Dehaye JP, Moran A, Marino A (1999) Purines, a new class of agonists in salivary glands? Arch Oral Biol 44:S39–S43
119. Scully C (2003) Drug effects on salivary glands: dry mouth. Oral Dis 9:165–176
120. Brinkmann V (2009) FTY720 (fingolimod) in multiple sclerosis: therapeutic effects in the immune and the central nervous system. Br J Pharmacol 158:1173–1182
121. Schwab SR, Cyster JG (2007) Finding a way out: lymphocyte egress from lymphoid organs. Nat Immunol 8:1295–1301
122. van Meeteren LA, Brinkmann V, Saulnier-Blache JS, Lynch KR, Moolenaar W (2008) Anticancer activity of FTY720: phosphorylated FTY720 inhibits autotaxin, a metastasisenhancing and angiogenic lysophospholipase D. Cancer Lett 266:203–208
123. Zheng T, Meng X, Wang J, Chen X, Yin D, Liang Y, Song X, Pan S, Jiang H, Liu L (2010) PTEN- and p53-mediated apoptosis and cell cycle arrest by FTY720 in gastric cancer cells and nude mice. J Cell Biochem 111:218–228
124. Jin-Hua P, Goding JW, Nakamura H, Sano K (1997) Molecular cloning and chromosomal localization of PD-Ibeta (PDNP3), a new member of the human phosphodiesterase I genes. Genomics 45:412–415
125. Fuss B, Baba H, Phan T, Tuohy VK, Macklin WB (1997) Phosphodiesterase I, a novel adhesion molecule and/or cytokine involved in oligodendrocyte function. J Neurosci 17:9095–9103
126. Stefan C, Gijsbers R, Stalmans W, Bollen M (1999) Differential regulation of the expression of nucleotide pyrophosphatases/phosphodiesterases in rat liver. Biochim Biophys Acta 1450:45–52
127. Picher M, Boucher RC (2001) Metabolism of extracellular nucleotides in human airways by a multienzyme system. Drug Dev Res 52:66–75
128. Picher M, Boucher RC (2000) Biochemical evidence for an ecto alkaline phosphodiesterase I in human airways. Am J Respir Cell Mol Biol 23:255–261
129. Morley DJ, Hawley DM, Ulbright TM, Butler LG, Culp JS, Hodes ME (1987) Distribution of phosphodiesterase I in normal human tissues. J Histochem Cytochem 35:75–82
130. Yano Y, Hayashi Y, Sano K, Shinmaru H, Kuroda Y, Yokozaki H, Yoon S, Kasuga M (2003) Expression and localization of ecto-nucleotide pyrophosphatase/phosphodiesterase I-3 (E-NPP3/CD203c/PD-I beta/B10/gp130RB13-6) in human colon carcinoma. Int J Mol Med 12:763–766
131. Petersen CB, Nyga°rd AB, Viuff B, Fredholm M, Aasted B, Salomonsen J (2007) Porcine ecto-nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1/CD203a): cloning, transcription, expression, mapping, and identification of an NPP1/CD203a epitope for swine workshop cluster 9 (SWC9) monoclonal antibodies. Dev Comp Immunol 31:618–631
132. Scott LJ, Delautier D, Meerson NR, Trugnan G, Goding JW, Maurice M (1997) Biochemical and molecular identification of distinct forms of alkaline phosphodiesterase I expressed on the apical and basolateral plasma membrane surfaces of rat hepatocytes. Hepatology 25:995–1002
133. Bello V, Goding JW, Greengrass V, Sali A, Dubljevic V, Lenoir C, Trugnan G, Maurice M (2001) Characterization of a di-leucine-based signal in the cytoplasmic tail of the nucleotidepyrophosphatase NPP1 that mediates basolateral targeting but not endocytosis. Mol Biol Cell 12:3004–3015
134. Meerson NR, Bello V, Delaunay JL, Slimane TA, Delautier D, Lenoir C, Trugnan G, Maurice M (2000) Intracellular traffic of the ecto-nucleotide pyrophosphatase/phosphodiesterase NPP3 to the apical plasma membrane of MDCK and Caco-2 cells: apical targeting occurs in the absence of N-glycosylation. J Cell Sci 113:4193–4202
135. Davis CW, Dickey BF (2008) Regulated airway goblet cell mucin secretion. Annu Rev Physiol 70:487–512
136. Hirsh AJ, Stonebraker J, van Heusden CA, Lazarowski ER, Boucher RC, Picher M (2007) Adenosine deaminase 1 and concentrative nucleoside transporters 2 and 3 regulate adenosine on the apical surface of human airway epithelia: implications for inflammatory lung diseases. Biochemistry 46:10373–10383
137. Saleh A, Picher M, Kammouni W, Figarella C, Merten MD (1999) Characterization of a diadenosine tetraphosphate-receptor distinct from the ATP-purinoceptor in human tracheal gland cells. Eur J Pharmacol 384:91–98
138. Lazarowski ER, Boucher RC (2009) Purinergic receptors in airway epithelia. Curr Opin Pharmacol 9:262–267
139. Yang Y, Mou L-j, Liu N, Tsao M-S (1999) Autotaxin expression in non-small-cell lung cancer. Am J Respir Cell Mol Biol 21:216–222
140. Gijsbers R, Ceulemans H, Stalmans W, Bollen M (2001) Structural and catalytic similarities between nucleotide pyrophosphatases/phosphodiesterases and alkaline phosphatases. J Biol Chem 276:1361–1368
141. van Meeteren LA, Moolenaar WH (2007) Regulation and biological activities of the autotaxin- LPA axis. Prog Lipid Res 46:145–160
142. Toews ML, Ediger TL, Romberger DJ, Rennard SI (2002) Lysophosphatidic acid in airway function and disease. Biochim Biophys Acta 1582:240–250
143. Zhao Y, Natarajan V (2009) Lysophosphatidic acid signaling in airway epithelium: role in airway inflammation and remodeling. Cell Signal 21:367–377
144. Balazs L, Okolicany J, Ferrebee M, Tolley B, Tigyi G (2001) Topical application of the phospholipid growth factor lysophosphatidic acid promotes wound healing in vivo. Am J Physiol 280:R466–R472
145. Cummings RJ, Parinandi N, Zaiman A, Wang L, Usatyuk PV, Garcia JG, Natarajan V (2002) Phospholipase D activation by sphingosine 1-phosphate regulates interleukin-8 secretion in human bronchial epithelial cells. J Biol Chem 277:30227–30235
146. Milara J, Mata M, Mauricio MD, Donet E, Morcillo EJ, Cortijo J (2009) Sphingosine- 1-phosphate increases human alveolar epithelial IL-8 secretion, proliferation and neutrophil chemotaxis. Eur J Pharmacol 609:132–139
147. Ryan JJ, Spiegel S (2008) The role of sphingosine-1-phosphate and its receptors in asthma. Drug News Perspect 21:89–96
148. Van Rompay AR, Johansson M, Karlsson A (2000) Phosphorylation of nucleosides and nucleoside analogs by mammalian nucleoside monophosphate kinases. Pharmacol Ther 87:189–198
149. Lacombe M-LL, Munier A, Mehus JG, Lambeth DO (2000) The human Nm23/nucleoside diphosphate kinases. J Bioenerg Biomembr 32:247–258
150. Dzeja PP, Terzic A (2003) Phosphotransfer networks and cellular energetics. J Exp Biol 206:2039–2047
151. Yegutkin GG, Henttinen T, Jalkanen S (2001) Extracellular ATP formation on vascular endothelial cells is mediated by ecto-nucleotide kinase activities via phosphotransfer reactions. FASEB J 15:251–260
152. Yegutkin GG, Henttinen T, Samburski SS, Spychala J, Jalkanen S (2002) The evidence for two opposite, ATP-generating and ATP-consuming, extracellular pathways on endothelial and lymphoid cells. Biochem J 367:121–128
153. Fabre AC, Vantourout P, Champagne E, Terce´ F, Rolland C, Perret B, Collet X, Barbaras R, Martinez LO (2006) Cell surface adenylate kinase activity regulates the F(1)-ATPase/P2Y13- mediated HDL endocytosis pathway on human hepatocytes. Cell Mol Life Sci 63:2829–2837
154. Karczewska J, Martyniec L, Dzierzko G, Stepinski J, Angielski S (2007) The relationship between constitutive ATP release and its extracellular metabolism in isolated rat kidney glomeruli. J Physiol Pharmacol 58:321–333
155. Burrell HE, Wlodarski B, Foster BJ, Buckley KA, Sharpe GR, Quayle JM, Simpson AWM, Gallagher JA (2005) Human keratinocytes release ATP and utilize three mechanisms for nucleotide interconversion at the cell surface. J Biol Chem 280:29667–29676
156. Lazarowski ER, Homolya L, Boucher RC, Harden TK (1997) Identification of an ectonucleoside diphosphokinase and its contribution to interconversion of P2 receptor agonists. J Biol Chem 272:20402–20407
157. Lazarowski ER, Boucher RC, Harden TK (2000) Constitutive release of ATP and evidence for major contribution of ecto-nucleotide pyrophosphatase and nucleoside diphosphokinase to extracellular nucleotide concentrations. J Biol Chem 275:31061–31068
158. Donaldson SH, Picher M, Boucher RC (2002) Secreted and cell-associated adenylate kinase and nucleoside diphosphokinase contribute to extracellular nucleotide metabolism on human airway surfaces. Am J Respir Cell Mol Biol 26:209–215
159. Picher M, Boucher RC (2003) Human airway ecto-adenylate kinase. A mechanism to propagate ATP signaling on airway surfaces. J Biol Chem 278:11256–11264
160. Conway JD, Bartolotta T, Abdullah LH, Davis CW (2003) Regulation of mucin secretion from human bronchial epithelial cells grown in murine hosted xenografts. Am J Physiol 284: L945–L954
161. Hunsucker SA, Mitchell BS, Spychala J (2005) The 50-nucleotidases as regulators of nucleotide and drug metabolism. Pharmacol Ther 107:1–30
162. Colgan SP, Eltzschig HK, Eckle T, Thompson LF (2006) Physiological roles for ecto-50- nucleotidase (CD73). Purinergic Signal 2:351–360
163. Salmi M, Jalkanen S (2005) Cell-surface enzymes in control of leukocyte trafficking. Nat Rev Immunol 5:760–761
164. Volmer JB, Thompson LF, Blackburn MR (2006) Ecto-50-nucleotidase (CD73)-mediated adenosine production is tissue protective in a model of bleomycin-induced lung injury. J Immunol 176:4449–4458
165. Gakis C (1996) Adenosine deaminase (ADA) isoenzymes ADA1 and ADA2: diagnostic and biological role. Eur Respir J 9:632–633
166. Franco R, Casado V, Ciruela F, Saura C, Mallol J, Canela EI, Lluis C (1997) Cell surface adenosine deaminase: much more than an ectoenzyme. Prog Neurobiol 52:283–294
167. Cristalli G, Costanzi S, Lambertucci C, Lupidi G, Vittori S, Volpini R, Camaioni E (2001) Adenosine deaminase: functional implications and different classes of inhibitors. Med Res Rev 21:105–128
168. Hershfield M (2005) New insights into adenosine-receptor-mediated immunosuppression and the role of adenosine in causing the immunodeficiency associated with adenosine deaminase deficiency. Eur J Immunol 35:25–30
169. Dong RP, Kameoka J, Hegen M, Tanaka T, Xu Y, Schlossman SF, Morimoto C (1996) Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response. J Immunol 156:1349–1355
170. Valenzuela A, Blanco J, Callebaut C, Jacotot E, Lluis C, Hovanessian A, Franco R (1997) HIV-1 envelope gp120 and viral particles block adenosine deaminase binding to CD26. Adv Exp Med Biol 421:185–192
171. Daddona PE, Kelley WN (1980) Analysis of normal and mutant forms of human adenosine deaminase–a review. Mol Cell Biochem 29:91–101
172. Matteucci E, Giampietro O (2009) Dipeptidyl peptidase-4 (CD26): knowing the function before inhibiting the enzyme. Curr Med Chem 16:2943–2951
173. Conlon BA, Law WR (2004) Macrophages are a source of extracellular adenosine deaminase- 2 during inflammatory responses. Clin Exp Immunol 138:14–20
174. Zavialov AV, Engstrom A (2005) Human ADA2 belongs to a new family of growth factors with adenosine deaminase activity. Biochem J 391:51–57
175. Tsuboi I, Sagawa K, Shichijo S, Yokoyama MM, Ou DW, Wiederhold MD (1995) Adenosine deaminase isoenzyme levels in patients with human T-cell lymphotropic virus type 1 and human immunodeficiency virus type 1 infections. Clin Diagn Lab Immunol 2:626–630
176. Daddona PE, Kelley WN (1981) Characteristics of an aminohydrolase distinct from adenosine deaminase in cultured human lymphoblasts. Biochim Biophys Acta 658:280–290
177. Zavialov AV, Gracia E, Glaichenhaus N, Franco R, Zavialov AV, Lauvau G (2010) Human adenosine deaminase 2 induces differentiation of monocytes into macrophages and stimulates proliferation of T helper cells and macrophages. J Leukoc Biol 88:279–290
178. Sauter C, Lamanna N, Weiss MA (2008) Pentostatin in chronic lymphocytic leukemia. Expert Opin Drug Metab Toxicol 4:1217–1222
179. Niedzwicki JG, Abernethy DR (1991) Structure-activity relationship of ligands of human plasma adenosine deaminase2. Biochem Pharmacol 41:1615–1624
180. Iwaki-Egawa S, Namiki C, Watanabe Y (2004) Adenosine deaminase 2 from chicken liver: purification, characterization, and N-terminal amino acid sequence. Comp Biochem Physiol 137:247–254
181. Andreasyan NA, Hairapetyan HL, Sargisova YG, Mardanyan SS (2005) ADA2 isoform of adenosine deaminase from pleural fluid. FEBS Lett 579:643–647
182. Ji XD, Ye F, Lin P, Zhao S (2010) Immobilized capillary adenosine deaminase microreactor for inhibitor screening in natural extracts by capillary electrophoresis. Talanta 82:1170–1174
183. Dilmac A, Ucoluk G, Ugurman F, Gozu A, Akkalyoncu B, Eryilmaz T, Samurkasoglu B (2002) The diagnostic value of adenosine deaminase activity in sputum in pulmonary tuberculosis. Respir Med 96:632–634
184. Akyol O, Gokbulut I, Koksal N, Akin H, Ozyurt H, Yildirim Z (2001) The activities of purine catabolizing enzymes in plasma and bronchial washing fluid in patients with lung cancer and pneumonia. Clin Biochem 34:251–254
185. Kayacan O, Karnak D, Delibalta M, Beder S, Karaca L, Tutkak H (2002) Adenosine deaminase activity in bronchoalveolar lavage in Turkish patients with smear negative pulmonary tuberculosis. Respir Med 96:536–541
186. Albera C, Mabritto I, Ghio P, Solidoro P, Marchetti L, Pozzi E (1993) Adenosine deaminase activity and fibronectin levels in bronchoalveolar lavage fluid in sarcoidosis and tuberculosis. Sarcoidosis 10:18–25
187. Orphanidou D, Stratakos G, Rasidakis A, Toumbis M, Samara J, Bakakos P, Jordanoglou J (1998) Adenosine deaminase activity and lysozyme levels in bronchoalveolar lavage fluid in patients with pulmonary tuberculosis. Int J Tuberc Lung Dis 2:147–152
188. Reechaipichitkul W, Lulitanond V, Patjanasoontorn B, Boonsawat W, Phunmanee A (2004) Diagnostic yield of adenosine deaminase in bronchoalveolar lavage. Southeast Asian J Trop Med Public Health 35:730–734
189. Blackburn MR, Kellems RE, Frederick WA (2005) Adenosine deaminase deficiency: metabolic basis of immune deficiency and pulmonary inflammation. Adv Immunol 86:1–41
190. Dinjens WN, ten Kate J, van der Linden EP, Wijnen JT, Khan PM, Bosman FT (1989) Distribution of adenosine deaminase complexing protein (ADCP) in human tissues. J Histochem Cytochem 37:1869–1875
191. Dinjens WN, ten Kate J, Wijnen JT, van der Linden EP, Beek CJ, Lenders MH, Khan PM, Bosman FT (1989) Distribution of adenosine deaminase-complexing protein in murine tissues. J Biol Chem 264:19215–19220
192. Ben-Shooshan I, Kessel A, Ben-Tal N, Cohen-Luria R, Parola AH (2002) On the regulatory role of dipeptidyl peptidase IV (CD26-adenosine deaminase complexing protein) on adenosine deaminase activity. Biochim Biophys Acta 1587:21–30
193. Wesley UV, Tiwari S, Houghton AN (2004) Role for dipeptidyl peptidase IV in tumor suppression of human non small cell lung carcinoma cells. Int J Cancer 109:855–866
194. Iwaki-Egawa S, Yamamoto T, Watanabe Y (2006) Human plasma adenosine 2 is secreted by activated monocytes. Biol Chem 387:319–321
195. van Waeg G, van den Berghe G (1991) Purine catabolism in polymorphonuclear neutrophils. Phorbol myristate acetate-induced accumulation of adenosine owing to inactivation of extracellularly released adenosine deaminase. J Clin Invest 87:305–312
196. Martinez-Valdez H, Cohen A (1988) Coordinate regulation of mRNAs encoding adenosine deaminase, purine nucleoside phosphorylase, and terminal deoxynucleotidyltransferase by phorbol esters in human thymocytes. Proc Natl Acad Sci USA 85:6900–6903
197. Baldwin SA, Beal PR, Yao SYM, King AE, Cass CE, Young JD (2004) The equilibrative nucleoside transporter family, SLC29. Pfl€ugers Arch Eur J Physiol 447:735–743
198. Gray JH, Owen RP, Giacomini KM (2004) The concentrative nucleoside transporter family, SLC28. Pflugers Arch Eur J Physiol 447:728–734
199. Griffith DA, Jarvis SM (1996) Nucleoside and nucleobase transport systems of mammalian cells. Biochim Biophys Acta 1286:153–181
200. Pastor-Anglada M, Errasti-Murugarren E, Aymerich I, Casado FJ (2007) Concentrative nucleoside transporters (CNTs) in epithelia: from absorption to cell signaling. J Physiol Biochem 63:97–110
201. Molina-Arcas M, Casado FJ, Pastor-Anglada M (2009) Nucleoside transporter proteins. Curr Vasc Pharmacol 7:426–434
202. Allen-Gipson DS, Jarrell JC, Bailey KL, Robinson JE, Kharbanda KK, Sisson JH, Wyatt TA (2009) Ethanol blocks adenosine uptake via inhibiting the nucleoside transport system in bronchial epithelial cells. Alcohol Clin Exp Res 33:791–798
203. Kreda SM, Seminario-Vidal L, van Heusden CA, O’Neal W, Jones L, Boucher RC, Lazarowski ER (2010) Receptor-promoted exocytosis of airway epithelial mucin granules containing a spectrum of adenine nucleotides. J Physiol 588:2255–2267
204. Kishioka C, Okamoto K, Kim J, Rubin BK (2001) Regulation of secretion from mucous and serous cells in the excised ferret trachea. Respir Physiol 126:163–171
205. Pitkanen OM, Smith D, O’Brodovich H, Otulakowski G (2001) Expression of alpha-, beta-, and gamma-hENaC mRNA in the human nasal, bronchial and distal lung epithelium. Am J Respir Crit Care Med 163:273–276
206. Kreda SM, Mall M, Mengos A, Rochelle L, Yankaskas JR, Riordan JR, Boucher RC (2005) Characterization of wild-type and deltaF508 cystic fibrosis transmembrane regulator in human respiratory epithelia. Mol Biol Cell 16:2154–2167
207. Boucher RC (2007) Airway surface dehydration in cystic fibrosis: pathogenesis and therapy. Annu Rev Med 58:157–170